Haemonetics Corporation  

(Public, NYSE:HAE)   Watch this stock  
Find more results for HAE
36.30
+0.29 (0.81%)
Aug 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 35.91 - 36.44
52 week 25.98 - 36.76
Open 36.07
Vol / Avg. 185,589.00/367,526.00
Mkt cap 1.86B
P/E     -
Div/yield     -
EPS -1.29
Shares 51.30M
Beta 0.80
Inst. own 102%
Nov 2, 2016
Q2 2017 Haemonetics Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 8, 2016
Haemonetics Corp at Robert W Baird Global Healthcare Conference - 3:10PM EDT - Add to calendar
Aug 1, 2016
Q1 2017 Haemonetics Corp Earnings Call - Webcast
Aug 1, 2016
Q1 2017 Haemonetics Corp Earnings Release
Jul 21, 2016
Haemonetics Corp Annual Shareholders Meeting
Jul 20, 2016
Haemonetics Corp Annual Shareholders Meeting (Estimated)
Jun 9, 2016
Haemonetics Corp at Jefferies Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '16) 2016
Net profit margin -4.93% -6.12%
Operating margin -3.75% -4.83%
EBITD margin - 17.12%
Return on average assets -3.15% -3.96%
Return on average equity -5.78% -7.18%
Employees 3,225 -
CDP Score - -

Address

400 WOOD RD
BRAINTREE, MA 02184-2412
United States - Map
+1-781-8487100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.

Officers and directors

Christopher Simon President, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
William P. Burke Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Thomas McCurdy President - Global Plasma
Bio & Compensation  - Reuters
Byron Selman President - Global Markets
Bio & Compensation  - Reuters
David D. Helsel Executive Vice President - Global Manufacturing
Age: 51
Bio & Compensation  - Reuters
Jonathan White Chief Science and Technology Officer
Age: 55
Bio & Compensation  - Reuters
Dan Goldstein Principal Accounting Officer
Bio & Compensation  - Reuters
Sandra Jesse Vice President, Chief Legal Officer
Age: 62
Bio & Compensation  - Reuters
Richard J. Meelia Non-Executive Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Ronald G. Gelbman Director
Age: 67
Bio & Compensation  - Reuters